Syneos Health Appoints William E. Klitgaard Independent Director
14 oct. 2022 16h45 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E....
Syneos Health Wins Triangle Business Journal 2022 Leaders in Diversity Award
13 oct. 2022 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has been awarded a Triangle...
Syneos Health Expands Partnership with Datavant to Accelerate Delivery of New Therapies to Patients
11 oct. 2022 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced an expanded partnership with...
Syneos Health Releases Annual Sustainability Report
05 oct. 2022 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report....
Syneos Health to Present at the 2022 Baird Global Healthcare Conference
30 août 2022 17h20 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Reports Second Quarter 2022 Results
02 août 2022 06h05 HE
|
Syneos Health, Inc.
Revenue for the second quarter of $1,360.7 million increased 6.1% on a reported basis and 8.3% on a constant currency basis year-over-year.Clinical Solutions net new business awards and book-to-bill...
Syneos Health Schedules Second Quarter 2022 Earnings Call for Tuesday, August 2, 2022
18 juil. 2022 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., July 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2022 financial...
Syneos Health to Present at Upcoming Investor Conferences
24 mai 2022 07h01 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 24, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to...
Syneos Health Leaders Recognized by HBA
10 mai 2022 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Kasey Boynton, MPH, MBA,...
Syneos Health Names Michelle Keefe as Next Chief Executive Officer
29 avr. 2022 06h26 HE
|
Syneos Health, Inc.
Alistair Macdonald to Retire After 20 Years in Variety of Leadership Roles Michael Brooks Named Chief Operating Officer Company Reports First Quarter 2022 Results and Updates Full Year Guidance ...